Literature DB >> 25348810

Impact of physicochemical environment on the super disintegrant functionality of cross-linked carboxymethyl sodium starch: insight on formulation precautions.

Michèle Delalonde1, Raja Fitouri, Emilie Ruiz, Bernard Bataille, Tahmer Sharkawi.   

Abstract

The aim of this work is to improve the understanding of the physicochemical mechanisms involved in the functionality of cross-linked carboxymethyl sodium starch (CCSS) as a tablet super disintegrant (SD). The behavior and properties of this SD (medium uptake, disintegration times, particle size, and rheology) was investigated in a wetting medium of different physicochemical properties. In particular, the relative permittivity (dielectric constant) of these media was intentionally modified for evaluating its effect on CCSS properties. Results showed different swelling behaviors of CCSS particles according to the relative permittivity of the tested media and allow to propose two underlying mechanisms that explain CCSS functionality. Both the intra-particular swelling and the inter-particular repulsion are affected by the relative permittivity of the media. Finally, disintegration test performed on tablets specially formulated with mannitol (used commonly as an excipient and known to modify relative permittivity) confirmed that the functionality of CCSS and therefore the disintegration of the tablet can be altered according to the mannitol content.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25348810      PMCID: PMC4370973          DOI: 10.1208/s12249-014-0121-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

Review 1.  Dissolution testing of orally disintegrating tablets.

Authors:  Johannes Kraemer; Jayachandar Gajendran; Alexis Guillot; Julian Schichtel; Akif Tuereli
Journal:  J Pharm Pharmacol       Date:  2012-04-08       Impact factor: 3.765

2.  Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.

Authors:  G Abdelbary; C Eouani; P Prinderre; J Joachim; Jp Reynier; Ph Piccerelle
Journal:  Int J Pharm       Date:  2005-03-23       Impact factor: 5.875

3.  The effects of relative humidity and super-disintegrant concentrations on the mechanical properties of pharmaceutical compacts.

Authors:  Christine Hersen-Delesalle; Bernard Leclerc; Guy Couarraze; Virginie Busignies; Pierre Tchoreloff
Journal:  Drug Dev Ind Pharm       Date:  2007-12       Impact factor: 3.225

4.  Effect of powder characteristics on oral tablet disintegration.

Authors:  Yoshihisa Yamamoto; Makiko Fujii; Ken-ichi Watanabe; Masashi Tsukamoto; Yusuke Shibata; Masuo Kondoh; Yoshiteru Watanabe
Journal:  Int J Pharm       Date:  2008-08-29       Impact factor: 5.875

5.  Understanding disintegrant action by visualization.

Authors:  Parind Mahendrakumar Desai; Celine Valeria Liew; Paul Wan Sia Heng
Journal:  J Pharm Sci       Date:  2012-03-15       Impact factor: 3.534

6.  Fundamental mechanisms for tablet dissolution: simulation of particle deaggregation via Brownian dynamics.

Authors:  Erik Kaunisto; Anders Rasmuson; Johan Bergenholtz; Johan Remmelgas; Lennart Lindfors; Staffan Folestad
Journal:  J Pharm Sci       Date:  2013-03-18       Impact factor: 3.534

7.  The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets.

Authors:  Na Zhao; Larry L Augsburger
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

8.  Dielectric measurements on electro-manipulation media.

Authors:  W M Arnold; A G Gessner; U Zimmermann
Journal:  Biochim Biophys Acta       Date:  1993-05-07
  8 in total
  1 in total

1.  Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.

Authors:  Anjali Agrawal; Mayur Dudhedia; Weibin Deng; Kevin Shepard; Li Zhong; Edward Povilaitis; Ewa Zimny
Journal:  AAPS PharmSciTech       Date:  2016-01-12       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.